December 31, 2015: Researchers First Used CRISPR to Treat a Genetic Disease in Mice
Researchers at the Duke University used CRISPR technology to treat Duchenne Muscular Dystrophy (DMD), and published the report on December 31, 2015 on Science journal. DMD is a genetic disease that can also occur in humans. This was the first case in which CRISPR technology is used to treat inherited diseases in adult mammals and was of great importance to the development of human gene therapy.
Reference
http://www.sciencemag.org/news/2015/12/crispr-helps-heal-mice-muscular-dystrophy
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115